| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |